This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This case report describes an atypical presentation of CAS in a 68-year-old white British male with cardiovascular riskfactors. The arrhythmias persisted despite initial medical management, including calcium channel blockers and intravenous glyceryl trinitrate.
Background To assess the roles of diabetic microvascular disease and modifiable riskfactors and their combination in the development of arrhythmias. Methods We included participants with type 2 diabetes (T2D) who were free of arrhythmias during recruitment in the UK Biobank study.
Patients who present with persistent atrial fibrillation at diagnosis are more likely to have certain riskfactors as compared with patients with occasional atrial fibrillation (AFib). The findings, led by investigators in the Smidt Heart Institute at Cedars-Sinai, published in Circulation: Arrhythmia and Electrophysiology.
Introduction Atrial fibrillation is the most prevalent sustained arrhythmia worldwide and is expected to increase substantially within the coming years.
Albuminuria is associated with an increased risk of coronary artery disease, stroke, heart failure, arrhythmias, and microvascular disease. There are now several therapeutic agents that can lead to albuminuria lowering and a reduction in cardiovascular risk. However, screening for albuminuria is still low.
Quit Smoking: Smoking is a significant riskfactor for heart disease. Your cardiologist can assess your riskfactors and implement preventive measures. RiskFactor Reduction: Strategies to address smoking, excessive alcohol consumption, and other modifiable riskfactors.
Research Highlights: A clinical trial with adults who have atrial fibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care.
Atrial fibrillation (AF) prediction improves by combining clinical scores with a polygenic risk score (PRS) for AF (AF-PRS), but there are limited studies of PRS for ventricular arrhythmia (VA) prediction.
111.87), arrhythmias were detected in 9 (33%) patients. We did not identify significant riskfactors for arrhythmias post-HT. Results We identified 27 children (66.7% males) with a median age of 15 years (IQR: 7–16) and a median weight of 45 kg (IQR: 22–66) at the time of the intervention. On a median follow-up of 35.07
A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrial fibrillation (AF) is still reported.1 A gradual increase in arrhythmia recurrences during 12 months after catheter ablation (CA) of atrial fibrillation (AF) is still reported.1
Risk stratification for atrial fibrillation (AF) and ventricular arrhythmia (VA) is suboptimal despite high cardiovascular (CV) comorbidity and mortality. AF has a strong genetic basis, but the genetic architecture of VA is less studied.
BackgroundAtrial dysfunction is a riskfactor for atrial arrhythmia and can be detected by atrial strain imaging in patients with biventricular circulation. Newonset and recurrent atrial arrhythmias were ascertained from baseline encounter to last followup.
Atrial fibrillation (AF) is the most common arrhythmia in the U.S., Black Americans are less prone to develop AF than White Americans, but they display a higher burden of modifiable riskfactors for cardiovascular disease and higher rates of ischemic stroke.
Arrhythmias, and in particular atrial fibrillation (AF), are one of the greatest healthcare challenges of our time. Arrhythmia prediction models have long relied on conventional riskfactors such as age, diabetes, hypertension, and history of myocardial infarction and heart failure.
A projected rise in heart disease and stroke – along with several key riskfactors, including high blood pressure and obesity – is likely to triple related costs to $1.8 It is not surprising that an enormous increase in cardiovascular riskfactors and diseases will produce a substantial economic burden."
Body weight (BW) and sympathetic nerve activity (SNA) are both important modifiable riskfactors for cardiac arrhythmias. However, a previous study showed that high BW is associated with low SNA in healthy subjects. No data are available on BW-SNA relationship during acute coronary syndrome (ACS) or mental stress.
Age is an independent riskfactor for the development of atrial fibrillation (AF). However, how natural aging predisposes to increased AF risk is currently unclear. Investigation prior to overt structural remodeling may therefore be required.
Type 2 diabetes mellitus (T2DM) is a major riskfactor for heart failure with preserved ejection fraction and cardiac arrhythmias. Precursors of these complications, such as diabetic cardiomyopathy, remain inc.
Risk stratification in patients with non-ischemic cardiomyopathy (NICM) remains challenging. Although late gadolinium enhancement (LGE) CMR is recognized as a major riskfactor for VT/VF, the prognostic value of LGE radiomics is unknown.
Increased Blood Clot Risk: Smoking enhances the bloods clotting tendency, raising the risk of heart attacks and strokes. These factors contribute to a host of cardiovascular problems, including coronary artery disease, heart failure, and arrhythmias, making smokers significantly more vulnerable to heart-related illnesses.
Low voltage area (LVA) and low conduction velocity (CV) are promising riskfactors to identify patients with abnormal atrial substrate at a high risk of atrial fibrillation (AF) recurrence following pulmonary vein isolation (PVI).
Additional relevant studies, published through November 2022, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate.StructureAtrial fibrillation is the most sustained common arrhythmia, and its incidence and prevalence are increasing in the United States and globally.
Abstract Background Postoperative atrial fibrillation (POAF) is the most frequent cardiac arrhythmia following cardiac operations. It has been associated with an increased risk of postoperative cerebrovascular complications, morbidity and mortality.
Multiple riskfactors for arrhythmia recurrence after Ventricular Tachycardia (VT) ablation have been identified. However, the cumulative impact of these riskfactors has not been evaluated, making it challenging to predict these risks in patients with multiple coexisting conditions.
This cohort study investigates the arrhythmic risk profile of carriers of filamin C truncating variants (FLNCtv) and the riskfactors associated with the risk of life-threatening ventricular arrhythmias.
Atrial fibrillation (AF) is the most prevalent arrhythmia in clinical practice, and obesity serves as a significant riskfactor for its development. The underlying mechanisms of obesity-related AF remain intri.
Cardiac accumulation triggers local tissue injury, electrical instability and arrhythmia. Objective We conducted a systematic review evaluating AF burden and bradycardia requiring permanent pacemaker (PPM) implantation and report any predictive riskfactors identified. Weighted estimate of event rates for AF were 12.2%
Cardiac arrhythmias are often encountered in orthotopic heart transplantation (OHT) recipients due to multiple riskfactors and may lead to the necessity of permanent pacemaker implantation(PPI). Ischemic time > 4 hours has been associated with graft dysfunction.
Asthma is a known riskfactor for atrial fibrillation (AF), the most common sustained arrhythmia. While radiofrequency catheter ablation is effective in treating AF, the impact of asthma and its severity on ablation outcomes has not been previously explored.
Atrial fibrillation is the most prevalent sustained cardiac arrhythmia and an important riskfactor for ischemic stroke resulting in a fivefold increased stroke risk. The clinical utility of polygenic risk scores for ischemic stroke prediction among atrial fibrillation patients has not yet been established.
Wearables that track sleep patterns can identify disruptions, such as sleep apnea, which is a known riskfactor for heart disease. Risk Reduction Data from wearables can identify potential risks, such as undiagnosed arrhythmias or hypertension, allowing healthcare teams to address these issues before surgery.
Hypertension is the single most important riskfactor for development of atrial fibrillation (AF), which may be considered as a cardiac manifestation of hypertensive target organ damage. Furthermore, coexistence of hypertension and AF mutually amplifies the risk of complications, such as heart failure and stroke.
Cardiomyopathy, a heterogeneous pathological condition characterized by changes in cardiac structure or function, represents a significant riskfactor for the prevalence and mortality of cardiovascular disease (CVD). Research conducted over the years has led to the modification of definition and classification of cardiomyopathy.
Use of tobacco cigarettes1 and marijuana2 have been associated with a heightened risk of atrial fibrillation (AF) in observational studies. We enrolled individuals that regularly consumed tobacco cigarettes, e-cigarettes, or inhaled marijuana to determine if acute exposure is associated with an increase in ectopy.
Atrial Fibrillation (AF) is a heart arrhythmia with influences from lifestyle riskfactors like alcohol use and obesity. As such, patient lifestyles have a prominent role in managing AF.
While this response is adaptive in the short term, chronic stress keeps your blood pressure elevated for extended periods, increasing your risk of hypertension (high blood pressure) and its associated complications, such as heart disease and stroke.
The key riskfactor for cardioembolic stroke is atrial fibrillation or flutter, and oral anticoagulation (OAC) is recommended in all but the lowest-risk patients with evidence of these arrhythmias. Riskfactors for thrombotic stroke overlap strongly with those for other atherosclerotic cardiovascular diseases (ASCVDs).
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi , revealed findings from a company-funded study of real-world data. AFib is the most common type of cardiac arrhythmia and affects more than 6 million people in the United States and nearly 38 million people worldwide.2,3 Circulation Research.
Understanding the riskfactors, recognizing the signs and seeking guidance from a cardiologist can play a significant role in preventing and treating this disease. Identifying Those at Risk for Heart Disease Heart disease describes a range of disorders that affect the cardiovascular system and the heart.
Background There is increasing awareness that patients without standard modifiable riskfactors (SMuRFs; diabetes, hypercholesterolaemia, hypertension and smoking) may represent a unique subset of patients with acute coronary syndrome (ACS). vs 3.6%, p=0.019) and arrhythmia (11.2% vs 9.9%, p=0.029).
Background Atrial fibrillation (AF), a common, frequently asymptomatic cardiac arrhythmia, is a major riskfactor for stroke. Identification of AF enables effective preventive treatment to be offered, potentially reducing stroke risk by up to two-thirds.
Female patients showed a lower prevalence rate of pre-existing coronary artery disease (48% vs. 75%, p < 0.001) and cardiomyopathy (17% vs. 34%, p = 0.01) compared with the male patients, while the mean age and prevalence rate of other cardiovascular riskfactors were balanced.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content